An Antitumor Fungal Polysaccharide from Fomitopsis Officinalis by Activating Immunity and Inhibiting Angiogenesis
Yongye Shen,Jiantong Hou,Wenhui Liu,Zhen Lin,Lingling Ma,Jing Xu,Yuanqiang Guo
DOI: https://doi.org/10.1016/j.ijbiomac.2024.131320
IF: 8.2
2024-01-01
International Journal of Biological Macromolecules
Abstract:Macrofungi, a class of unique natural resources, are gaining popularity owing to their potential therapeutic benefits and edibility. From Fomitopsis officinalis, , a medicinal macrofungus with anticancer activity, a homogeneous heteropolysaccharide (FOBP50-1) with a molecular weight of 2.21 x 104 4 g/mol has been extracted and purified. FOBP50-1 was found to be composed of 3-O-methylfucose, O-methylfucose, fucose, mannose, glucose, and galactose with a ratio of 1: 6.5: 4.4: 8.1: 18.2. The sugar fragments and structure of FOBP50-1 were investigated, which included-*6)-alpha-D-Galp-(1-*,- D-Gal p-(1-*,-*2,6)-alpha-D-Galp-(1-*, D-Gal p-(1-*,-*3)-alpha-L-Fucp-(1-*, L-Fuc p-(1-*, alpha-D-Glcp-(1-*, D-Glc p-(1-*,-*3)-(I-D-Manp-(1-*, D-Man p-(1-*,-*6)(I-D-Manp-(1-*, D-Man p-(1-*, 3-O-Me-alpha-L-Fucp-(1-*, O-Me-alpha- L-Fuc p-(1-*, according to the UV, FT-IR, GC-MS, and NMR data. Besides the structure elucidation, FOBP50-1 showed promising antitumor activity in the zebrafish assays. The following mechanism examination discovered that FOBP50-1 interacted with TLR-4, PD-1, and VEGF to activate immunity and inhibit angiogenesis according to a series of cell, transgenic zebrafish, and surface plasmon resonance (SPR) experiments. The K D values indicating the association of FOBP50-1 with TLR-4, PD-1, and VEGF, were 4.69 x 10-5,-5 , 7.98 x 10-6,-6 , 3.04 x 10-6-6 M, respectively, in the SPR experiments. All investigations have demonstrated that the homogenous fungal polysaccharide FOBP50-1 has the potential to be turned into a tumor immunotherapy agent.